# Astellas Pharma Inc. - Inspection Records

Source: https://www.keypedia.com/companies/astellas-pharma-inc/23dd5b22-f65a-44d8-ba32-8de91558f67f

> Inspection records and compliance data for Astellas Pharma Inc. in Takahagi, None. Access full analysis and detailed observations.

---

## Details

- Name: Astellas Pharma Inc.
- FEI Number: 3002808523
- City: Takahagi
- State: None
- Country Name: Japan
- Address Line 1: 160-2, Oazaakahama
- Zip Code: None

## Related Documents

- [483 - Astellas Pharma Inc. - 2025-06-06](https://www.keypedia.com/records/483/astellas-pharma-inc/32a3ab54-7cab-4e92-8a35-8eeb9b7b1d92) — source: FDA, date: June 6, 2025
- [FDA Inspection 1274304 - Astellas Pharma Inc. - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/94872362-abf5-4e6b-9d98-eeae80d432f2) — source: FDA, date: June 6, 2025
- [FDA Inspection 1274304 - Astellas Pharma Inc. - 2025-06-06](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a0c6d68f-877a-4b4d-bcc2-fdcf4c30a727) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 6, 2025
- [FDA Inspection 1076386 - Astellas Pharma Inc. - 2018-12-13](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/a7ea92a0-d1df-42dc-9013-79b27fde200b) — classification: No Action Indicated (NAI), source: FDA, date: December 13, 2018
- [FDA Inspection 886634 - Astellas Pharma Inc. - 2014-06-27](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/607e23b3-386b-4f56-b934-1263f6ffe731) — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2014
- [FDA Inspection 633570 - Astellas Pharma Inc. - 2009-10-15](https://www.keypedia.com/records/fda_inspections/astellas-pharma-inc/05b3849d-f185-4df1-b1b1-4ad80e215f1c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 15, 2009

## Related Companies

- [Cambrex Charles City, Inc.](https://www.keypedia.com/companies/cambrex-charles-city-inc/b14d342b-e5ae-4df6-ad7a-39cd62dfb9c6)
- [Livzon New North River Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/livzon-new-north-river-pharmaceutical-co-ltd/49cdcdc8-9c6c-4486-b6cd-e404c21dd2d2)
- [Olon S.p.A.](https://www.keypedia.com/companies/olon-spa/7e0ac35e-0f38-43f3-8415-015a3d5c0248)
- [Ajinomoto Co., Inc.](https://www.keypedia.com/companies/ajinomoto-co-inc/0cddfef7-b7e4-499f-81aa-0d5e77d331d4)
- [FUJIFILM Diosynth Biotechnologies UK Limited](https://www.keypedia.com/companies/fujifilm-diosynth-biotechnologies-uk-limited/1ab271fe-bbf2-4dec-a2b8-1ae59ca0f082)
- [Nippon Protein Co., Ltd. Ashikaga Plant](https://www.keypedia.com/companies/nippon-protein-co-ltd-ashikaga-plant/ccd4e515-8d9e-4f63-9a5d-b117cf2659d6)
- [Cambrex Karlskoga AB](https://www.keypedia.com/companies/cambrex-karlskoga-ab/c3f2350f-a38e-4e0c-9bac-e94c0255764c)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [Neuland Laboratories Limited (Unit I)](https://www.keypedia.com/companies/neuland-laboratories-limited-unit-i/2ab72f34-8d5a-4919-8777-83a4fa3cadd5)

## Related Officers

- [Investigator](https://www.keypedia.com/people/jacob-g-lutz/ca2710c6-064f-4728-9129-aad73e74f12d)